Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Established Evidence Results

Results for Measure: Postpartum Visit

Below are articles that support specific interventions to advance MCH National Performance Measures (NPMs) and Standardized Measures (SMs). Most interventions contain multiple components as part of a coordinated strategy/approach.

You can filter by intervention component below and sort to refine your search.

Start a New Search

Displaying records 1 through 1 (1 total).

Stotts, A. L., Villarreal, Y. R., Green, C., Berens, P., Blackwell, S., Khan, A., Suchting, R., Velasquez, M., Markham, C., Klawans, M. R., & Northrup, T. F. (2022). Facilitating treatment initiation and reproductive care postpartum to prevent substance-exposed pregnancies: A randomized bayesian pilot trial. Drug and alcohol dependence, 239, 109602. https://doi.org/10.1016/j.drugalcdep.2022.109602

Evidence Rating: Emerging

Intervention Components (click on component to see a list of all articles that use that intervention): Motivational Interviewing,

Intervention Description: A brief, hospital-initiated, adaptive motivational interviewing plus acceptance and commitment therapy (MIACT) intervention to facilitate substance-use treatment initiation and reproductive planning postpartum among mothers who used substances during pregnancy. The brief MIACT was developed as an adaptive intervention with treatment intensity (1, 2 or 3 sessions; about 45 min each) dependent upon verification of participant response. The MIACT intervention was delivered by masters-level counselors or a doctoral-level social worker. Participants assigned to the CC condition met with a trained research assistant and/or NICU social worker who offered support along with a list of referrals for substance use disorder treatment.

Intervention Results: Results indicated that during treatment the MIACT group demonstrated an 84% probability of benefit relative to CC with regard to initiating treatment (RR=1.5), however the effect was not seen at follow-up. MIACT was also associated with an increased probability of attending a postpartum obstetrics visit (RR=1.4), and receiving contraception during treatment and at both follow-ups, with posterior probabilities of 96% or higher and relative risks ranging from 1.5 to 5.1 at varying timepoints. Substance use rates for the MIACT versus CC were higher at follow-up.

Conclusion: Brief, hospital-initiated interventions can assist postpartum mothers who use substances to enter treatment and obtain contraception in order to reduce future substance-exposed pregnancies.

Study Design: Parallel group, randomized controlled design

Setting: Hospital

Population of Focus: Mothers with an infant admitted to a neonatal intensive care unit if they or their infant tested positive for an illicit substance at delivery or had a documented positive drug screen during pregnancy

Sample Size: 64

Age Range: Women of chilbearing age

Access Abstract

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.